Palo Capital’s Pediatrix Medical MD Stock Holding History

Palo Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-25,032	Closed	-$1.67M	–	133
2016 Q4	$1.67M	Buy	+25,032	New	+$1.63M	1.05%	41
2015 Q3	–	Sell	-27,940	Closed	-$2.07M	–	140
2015 Q2	$2.07M	Sell	27,940 -2,296	-8%	-$165K	1.62%	7
2015 Q1	$2.19M	Sell	30,236 -466	-2%	-$32.4K	1.79%	10
2014 Q4	$2.03M	Buy	+30,702	New	+$1.87M	1.71%	8

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Palo Capital's MD Position: Q1 2017 in Review

Palo Capital sold out of Pediatrix Medical (MD) in Q1 2017, closing a stake of 25,032 shares — an estimated $1.67M sold.

Palo Capital first reported a position in MD in Q4 2014 and held it in 4 quarters. The position peaked at $2.19M in Q1 2015. 359 funds tracked by Wall St. Rank hold MD as of Q1 2017.

Palo Capital reported no remaining Pediatrix Medical position as of Q1 2017 after selling out during the quarter.
Palo Capital sold 25,032 Pediatrix Medical shares in Q1 2017, an estimated $1.67M.
Palo Capital first reported a position in Pediatrix Medical in Q4 2014 and held it in 4 quarters.
Palo Capital's Pediatrix Medical position peaked at $2.19M in Q1 2015.
359 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2017.

Based on Palo Capital's 13F filing for Q1 2017, filed 26 Apr 2017.